Human umbilical cord-derived mesenchymal stem cells attenuate liver fibrosis by inhibiting hepatocyte ferroptosis through mitochondrial transfer

This publication has 59 references indexed in Scilit:

• Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis
  International Immunopharmacology, 2024
• Ferroptosis: An important mechanism of disease mediated by the gut-liver-brain axis
  Life Sciences, 2024
• Oxidative Stress–Induced Liver Damage and Remodeling of the Liver Vasculature
  The American Journal of Pathology, 2023
• Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery
  Journal of Controlled Release, 2023
• Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases
  Biochemical Pharmacology, 2022
• Progress in mesenchymal stem cell mitochondria transfer for the repair of tissue injury and treatment of disease
  Biomedicine & Pharmacotherapy, 2022
• Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
  Clinical Gastroenterology and Hepatology, 2020
• The emerging antioxidant paradigm of mesenchymal stem cell therapy
  Stem Cells Translational Medicine, 2020
• Emerging evidence for crosstalk between Nrf2 and mitochondria in physiological homeostasis and in heart disease
  Archives of Pharmacal Research, 2019
• Miro 1 Knockdown in Stem Cells Inhibits Mitochondrial Donation Mediated Rescue of Bronchial Epithelial Injury
  Biophysical Journal, 2013